- Home
- CBUS vs ALGS Comparison
CBUS vs ALGS Comparison
Compare CBUS & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBUS
- ALGS
- Stock Information
- Founded
- CBUS 2010
- ALGS 2018
- Country
- CBUS United States
- ALGS United States
- Employees
- CBUS N/A
- ALGS N/A
- Industry
- CBUS Agricultural Chemicals
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CBUS Industrials
- ALGS Health Care
- Exchange
- CBUS Nasdaq
- ALGS Nasdaq
- Market Cap
- CBUS 69.9M
- ALGS 56.7M
- IPO Year
- CBUS 2017
- ALGS 2020
- Fundamental
- Price
- CBUS $1.34
- ALGS $9.10
- Analyst Decision
- CBUS Strong Buy
- ALGS Strong Buy
- Analyst Count
- CBUS 2
- ALGS 2
- Target Price
- CBUS $21.25
- ALGS $60.00
- AVG Volume (30 Days)
- CBUS 172.9K
- ALGS 88.0K
- Earning Date
- CBUS 11-13-2025
- ALGS 11-06-2025
- Dividend Yield
- CBUS N/A
- ALGS N/A
- EPS Growth
- CBUS N/A
- ALGS N/A
- EPS
- CBUS N/A
- ALGS N/A
- Revenue
- CBUS $3,794,000.00
- ALGS $2,646,000.00
- Revenue This Year
- CBUS $17.67
- ALGS N/A
- Revenue Next Year
- CBUS $63.43
- ALGS N/A
- P/E Ratio
- CBUS N/A
- ALGS N/A
- Revenue Growth
- CBUS N/A
- ALGS N/A
- 52 Week Low
- CBUS $1.09
- ALGS $3.76
- 52 Week High
- CBUS $4.96
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CBUS 50.07
- ALGS 58.83
- Support Level
- CBUS $1.24
- ALGS $5.81
- Resistance Level
- CBUS $1.39
- ALGS $7.00
- Average True Range (ATR)
- CBUS 0.10
- ALGS 0.77
- MACD
- CBUS -0.00
- ALGS 0.33
- Stochastic Oscillator
- CBUS 90.00
- ALGS 89.56
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.